1. Stocks
  2. Gland Pharma Ltd.
  3. Swot
swot-logo

Gland Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Gland Pharma Ltd. has 18 Strengths, 9 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Strong Momentum: Price above short, medium and long term moving averages

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Degrowth in Revenue and Profit

Annual net profit declining for last 2 years

Fall in Quarterly Revenue and Net Profit (YoY)

FII / FPI or Institutions increasing their shareholding

MFs decreased their shareholding last quarter

Insiders sold stocks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Decline in Quarterly Net Profit with falling Profit Margin (YoY)